Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 3.70% | $2.18M | CHF220.01B | 29.42% | 80 Outperform | |
| Unilever | 2.53% | $1.50M | £103.83B | -7.73% | 72 Outperform | |
| Royal Bank Of Canada | 2.33% | $1.38M | $236.86B | 40.35% | 75 Outperform | |
| Sanofi | 1.88% | $1.11M | €97.84B | -7.10% | 75 Outperform | |
| Nestlé SA | 1.60% | $942.98K | CHF190.30B | 15.42% | 71 Outperform | |
| Canadian Bank of Commerce | 1.57% | $925.77K | C$119.03B | 47.38% | 74 Outperform | |
| Air Liquide | 1.52% | $894.83K | €92.05B | -1.46% | 66 Neutral | |
| Mitsubishi | 1.51% | $892.79K | ¥15.37T | 64.54% | 60 Neutral | |
| Iberdrola | 1.47% | $870.77K | €122.61B | 37.97% | 67 Neutral | |
| ASML Holding NV | 1.44% | $851.27K | €445.85B | 57.00% | 76 Outperform |